-
Product Insights
NewFujirebio Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Fujirebio Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc, is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent controls, EIA kits, and other test kits, among others. Its serum products comprise enzyme conjugate stabilizer, glycated human hemoglobin animal serums, and...
-
Sector Analysis
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2033. The market growth is attributed to the increasing number of immunochemistry analyzers. Immunochemistry Analyzers Market Outlook 2023-2033 ($ Billion) Buy Full Report for More Insights on the Immunochemistry Analyzers Market Forecast Download a Free Sample Report The immunochemistry analyzers market research report identifies quantitative market trends within in vitro diagnostics therapeutic...
-
Sector Analysis
Netherlands Renewable Energy Policy Handbook, 2024 Update
Netherlands Renewable Energy Policy Report Overview The Electricity Act is the major energy regulation in the Netherlands. The Act introduced the Third Energy Package Directives and Regulations in its amendment on 12th July 2012. The Authority for Consumers and Markets (ACM) is responsible for supervising compliance with the act. The country is also regulated by European Union (EU) directives. The government adopted the National Coordination Regulation to develop renewable power facilities and achieve renewable targets. The National Coordination Regulation combines...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Sector Analysis
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Helicobacter Pylori Tests Market Report Overview The Helicobacter Pylori tests market size was $338.5 million in 2023 and will grow at a CAGR of more than 2% from 2023 to 2033. Helicobacter Pylori tests are used in medicine to determine the presence of Helicobacter pylori (H, pylori) bacteria in the stomach or intestines which is responsible for causing gastrointestinal issues. These tests can aid in the diagnosis of H. pylori infections and the monitoring of treatment efficacy. Helicobacter Pylori Tests...
-
Sector Analysis
Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Bordetella pertussis (Whooping Cough) Tests Market Report Overview The Bordetella pertussis (Whooping Cough) test market size was $31.7 million in 2023 and will grow at a declining CAGR of less than 1% from 2023 to 2033. Bordetella pertussis (Whooping Cough) tests are carried out to detect infections caused by the bacterium Bordetella pertussis, using a combination of molecular techniques, immunoassay, and other techniques. Bordetella pertussis (Whooping Cough) Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights...
-
Sector Analysis
Treponema Pallidum Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Treponema Pallidum Tests Market Report Overview The treponema pallidum tests market size was $540.5 million in 2023. Â Factors such as the increasing prevalence of syphilis, as well as growing public awareness will drive the market growth at a CAGR of more than 3% during 2023-2033. Treponema pallidum is the causative organism for Syphilis and cannot be cultivated in vitro, resulting in a need for specific IVD tests, rather than the more usual bacteriology testing. The identification of the Treponema pallidum...
-
Sector Analysis
Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Human Immunodeficiency Virus (HIV) Tests Market Report Overview The HIV tests market size was valued at $1.97 billion in 2023 and will grow at a CAGR of more than 2% during 2023-2033. HIV tests are used to screen numerous different sample types including suspected infection cases, pregnant women, semen donations, whole blood donations, and source plasma donations. Significantly, this means that the market is relatively robust as it is not dependent on only one disease indication. Human Immunodeficiency Virus (HIV)...
-
Sector Analysis
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Hepatitis B tests Market Report Overview The hepatitis B tests market size was valued at $1.75 billion in 2023. The hepatitis B tests market will grow at a CAGR of more than 2% from 2023 to 2033. Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV). The virus attacks the liver and can cause acute and chronic disease, which might lead to liver failure, liver cancer or liver cirrhosis, kidney disease, and/or inflammation of blood vessels....
-
Sector Analysis
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Clostridium Difficile Tests Market Report Overview The clostridium difficile tests market size was $172.1 million in 2023. The market will decline at a CAGR of more than 1% from 2023 to 2033. Clostridium Difficile Tests are carried out to diagnose the bacterium, commonly known as C. diff, which is a major cause of serious diarrheal infections, and may also cause colon cancer. Clostridium Difficile Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights on the Clostridium...